Integrated human organ-on-a-chip model for predictive studies of anti-tumor drug efficacy and cardiac safety

Abstract

In a novel, integrated platform, integration of human bone tumor and cardiac tissues improved predictive accuracy of linsitinib efficacy and safety. This platform mimicked clinical trial results, unlike other pre-clinical models.